Percutaneous portal vein embolisation in preparation for extended hepatic resection of primary nonresectable liver tumours

Digestive and Liver Disease

Volumn 35, Issue 10, 2003, Pages 716-721

  Ladurner, R ^a   Brandacher, G ^a   Riedl Huter, C ^a   Steurer, W ^a   Spechtenhauser, B ^a   Waldenberger, P ^a   Margreiter, R ^a   Konigsrainer A ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Embolisation; Liver tumours; Resection

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LEVAMISOLE; METHOTREXATE; OXALIPLATIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CANCER; LIVER RESECTION; MALE; PORTAL VEIN; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE;

EID: 2142656118     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00415-8     Document Type: Article

References (22)

1. Azoulay D, Raccuia JS, Castaing D, Bismuth H. Right portal vein embolisation in preparation for major hepatic resection. J Am Coll Surg 1995;181:267-9.
2. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 1995;117:677-81.
3. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107:521-7.
4. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000;231:480-6.
5. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001;88:165-75.
6. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangave Hicks M, et al. Standardised measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000;127:512-9.
7. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003;237:208-17.
8. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 1999;29:1099-105.
9. Ishikawa M, Yogita S, Iuchi M, Yagi K, Chikaishi H, Fukuda Y, et al. Experimental and clinical studies on liver regeneration following transcatheter portal embolization. Hepato-Gastroenterology 2000;47:226-33.
10. Baere T, Roche A, Vavasseur D, Therasse E, Indushekar S, Elias D, et al. Portal vein embolization: utility for inducing left hepatic hypertrophy before surgery. Radiology 1993;188:73-7.
11. Yamakado K, Takeda K, Matsumura K, Nakatsuka A, Hirano T, Kato N, et al. Regeneration of the un-embolized liver parenchyma following portal vein embolization. J Hepatol 1997;27:871-80.
12. Shimamura T, Nakajima Y, Une Y, Namieno T, Ogasawara K, Yamashita K, et al. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery 1997;121:135-41.
13. Koyama K, Takagi Y, Ito K, Sato T. Experimental and clinical studies on the effect of biliary drainage in obstructive jaundice. Am J Surg 1981;142:293-9.
14. Miyata K. Delayed recovery of mitochondrial function in rat liver after releasing biliary obstruction. Nagoya J Med Sci 1983;45:97-105.
15. Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 1996;223:77-83.
16. Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, et al. Long term survival of patients with unresectbale colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999;10:663-9.
17. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet 2000;355:1041-7.
18. Biasco G, Gallerani E. Treatment of liver metastases from colorectal cancer: what is the best approach today? Dig Liver Dis 2001;33:438-44.
19. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-22.
20. Elias D, Baere T, Roche A, Ducreux M, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999;86:784-8.
21. Panis Y, Ribeiro J, Chretien F, Nordlinger B. Dormant liver metastases: an experimental study. Br J Surg 1992;79:221-3.
22. Slooter GD, Marquet RL, Jeekel J, Ijzermans JN. Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor alpha. Br J Surg 1995;82:129-32.